Atherosclerosis is a major contributor to cardiovascular disease, and genetic disorders of lipoprotein metabolism are recognized risk factors in atherogenesis. The gaseous monoxides nitric oxide (NO) and carbon monoxide (CO), generated within the blood vessel wall, have been identified as important cellular messengers involved in the regulation of vascular smooth muscle tone. Microsomal heme oxygenases degrade heme to biliverdin and CO, and the cytosolic enzyme biliverdin reductase then catalyzes reduction of biliverdin to bilirubin, both powerful chain-breaking antioxidants. Two principal isozymes of heme oxygenase have been identified, a constitutive isoform HO-2 (M |34 000) and an inducible isoform HO-1 (M |32 000), which is expressed at a low basal level in vascular endothelial r r and smooth muscle cells and is induced by heavy metals, oxidative stress, inflammatory mediators and oxidized low density lipoproteins. Although NO and CO modulate intracellular cGMP levels, platelet aggregation and smooth muscle relaxation, CO has a much lower affinity for soluble guanylyl cyclase than NO. Decreased production or sensitivity to NO in atherosclerosis may be compensated for by an induction of HO-1, with bilirubin acting as a cellular antioxidant and CO as a vasodilator. This review examines the evidence that oxidized low density lipoproteins (LDL), hypoxia and pro-inflammatory cytokines induce HO-1 expression and activity in vascular endothelial and smooth muscle cells, and evaluates the anti-atherogenic potential of the heme oxygenase signalling pathway.
Introduction
sions [7] and vascular endothelial and smooth muscle cells exposed to oxidized LDL [8,9] may serve a multi-purpose Over the past decade the field of cardiovascular research role, via metabolism to the antioxidant biliverdin and the has increasingly embraced the hypothesis of 'free radical vasodilator carbon monoxide (CO) [10, 11] . These adaptive attack' to explain the pathogenesis of vascular disease and responses may contribute to the maintenance of vascular the 'cardioprotective' role of antioxidants [1] . The emtone and patency in atherosclerotic vessels and compensate phasis has been on the pathogenesis of atherosclerosis and for diminished nitric oxide (NO) generation and activity vascular dysfunction associated with elevated plasma [12, 13] . This review summarises the evidence that the levels of low density lipoproteins (LDL) and their oxidaheme oxygenase-CO signalling pathway plays a physiotive modification [2] . Oxidized LDL and reactive oxygen logical role in the vasculature and evaluates its potential species influence vascular cell gene expression [3, 4] , significance in the pathogenesis of atherosclerosis. promoting atherogenesis and endogenous antioxidant defences to counteract and prevent further oxidative damage [5, 6] . Increased expression of the stress response protein 2. Heme metabolism and regulation of heme heme oxygenase-1 (HO-1) in human atherosclerotic leoxygenase induction vasculature [15] . These isoforms are products of different genes, with HO-1 and HO-2 sharing only |40% amino acid homology and HO-3 more closely related to HO-2 (|90%) (see Table 1 ). The catalytic activity of HO requires the concerted action of microsomal NADPH-cytochrome P450 reductase to transfer electrons to the heme-HO complex, which may account for their close cellular localisation [12] . Various regulatory elements in the 59 flanking region of the human, rat and mouse HO-1 gene and associated transcription factors have been identified [16] and may be involved in HO-1 gene activation in response to hydrogen inducer-responsive element, designated stress response reductase, to form biliverdin, iron and carbon monoxide. Biliverdin is element (StRE) [17] contains the sequence of the binding subsequently converted to bilirubin by biliverdin reductase. Carbon monoxide can activate soluble guanylyl cyclase in the cell in which CO is site for the transcription factor AP-1, and inhibition of its produced or in an adjacent cell by binding to its heme moiety. Activation activation has recently been shown to decrease HO-1 of soluble guanylyl cyclase results in elevated cyclic guanosine monomRNA expression in cytokine-treated human vascular phosphate levels (cGMP) formed from guanosine triphosphate (GTP).
endothelial cells [18] . Transcriptional activation of genes Adapted from Marks et al. [10] .
by electrophilic agents such as diethylmaleate (DEM), known to conjugate cellular glutathione, is mediated by an electrophile response element (EpRE), also designated pathways, as the prosthetic moiety of hemoproteins is antioxidant responsive element (ARE) [19] . Since DEM involved in cell respiration and oxidative biotransformacan induce HO-1 in vascular endothelial and smooth tions, including hemoglobin and myoglobin, cytochrome muscle cells [9, 20] , it is possible that EpRE-binding P450, nitric oxide synthase (NOS) and soluble guanylyl protein(s), in addition to AP-1, mediate HO-1 gene exprescyclase [11, 14] (Fig. 1) . Heme oxygenase plays an imsion. In addition, NF-kB and AP-2 consensus binding sites portant biological role in the degradation of heme to have been identified in the regulatory sequences of the regulate hemoprotein levels and protects cells from the human HO-1 gene promoter region [21] . Thus, activation deleterious effects of free heme [11] . Two isozymes of of AP-1, AP-2 and NF-kB may also be involved in the HO, expressed in the vasculature, have been characterized induction of HO-1 in vascular cells in atherogenesis [7, 22] . extensively, a 32 000 Da inducible isoform (HO-1) and a Although oxidatively modified LDL and pro-inflammatory 36 000 Da constitutive isoform (HO-2) [11] . A third cytokines can activate these transcription factors in cells 33 000 Da constitutive isoform (HO-3) has been identified [3, 4, 23] , NF-kB is only activated within cells of the in brain, heart, kidney, liver, testis and spleen, yet to date atherosclerotic lesion but not in normal vessels [22, 24] . there is no evidence that this isoform is expressed in the HO-2 has been shown to be up-regulated by glucocor- ticoids in the brain [25] , although its vascular expression patients with coronary heart disease, vasodilatation in appears to be constitutive [26] .
response to NO donors may also involve the heme oxygenase pathway, since these compounds have been reported to induce HO-1 in vascular cells [34, 42] . Levels of heme are elevated in atherosclerotic plaques 3. Oxidative stress in atherogenesis due to the release of hemoproteins from necrotic and ruptured cells present within lesions leading to further Vascular cells respond to an environment of 'oxidative LDL oxidation [43] and vascular cell toxicity [44] . Inducstress', such as that found within the milieu of the tion of HO-1 by heme serves to remove this pro-oxidant, developing atherosclerotic lesion, by inducing endogenous while concomitant induction of ferritin expression [45] [20, 29] . Diminished production of NO by human proteins [50] . endothelial cells depleted of GSH [30] may contribute to the impaired vascular reactivity associated with atherogenesis [12] . HO-1 is expressed in a variety of cells 4. Regulation of vascular tone by carbon monoxide under conditions where GSH is overwhelmed by oxidant insult [30, 31] . Moreover, it has recently been shown that a
The mechanism by which CO activates soluble guanylyl there is a diminished glutathione-related enzymatic anticyclase (sGC) is similar to that of NO, and involves oxidant shield within human atherosclerotic lesions [32] , binding and dislocation of its heme-iron to induce a and thus HO-1 induction may act as an alternative anticonformational change and activation of the catalytic site oxidant defence mechanism. As summarized in Tables 2 of guanylyl cyclase [10,11]. Endothelium-derived CO or and 3, induction of HO-1 in endothelial and smooth NO diffuses to subjacent smooth muscle cells where muscle cells by pro-atherogenic agents, such as heme [33] , activation of sGC results in elevated intracellular cGMP oxidized LDL [8,9], lipid metabolites [8, 31] , peroxynitrite levels leading to smooth muscle relaxation [51] . As [34] , hypoxia [35] [36] [37] , heavy metals [9,38] pro-inflammaillustrated in Fig. 2 , CO and NO can also be generated in tory cytokines [18, 39, 40] and angiotensin II [41] could smooth muscle cells in response to atherogenic stimuli or provide a secondary line of antioxidant defence and pro-inflammatory cytokines, respectively. The metabolic maintain vessel patency through the generation of CO. In and functional links between CO and NO suggest that [41] vasodilator actions of CO may become important in ing from one study to another. CO relaxes precontracted atherogenesis, where endothelium-derived NO production rabbit and dog aortic rings, with half maximal relaxation is inhibited.
achieved between 20 and 40 mM [52]. In this study, the The effects of CO on vascular smooth muscle relaxation relative potency of CO to NO varied from 1:1000 for are blood vessel and species specific, with findings differrabbit aorta to 1:1 for canine circumflex coronary artery.
As the ability of NO to directly activate sGC is |50-fold greater than CO [51], vasodilator actions of CO may be of particular importance in atherogenesis. The fact that heme [53] , a potent inducer of HO-1, lowers blood pressure in spontaneously hypertensive rats suggests that endogenous CO formation may be sufficient to stimulate vascular smooth muscle relaxation in vivo. Further evidence for a physiological role of CO in regulating vascular tone is provided by the findings of Johnson et al. [54] , who demonstrated a basal vasodepressor function of CO in normal rats. Inhibition of HO activity by administration of zinc deuteroporphyrin-2,4-bisglycol (a HO inhibitor) increases mean arterial blood pressure and total peripheral resistance [54] . This group subsequently reported that substrates for HO acutely lower blood pressure in ge- Fig. 2 . Importance of the heme oxygenase-carbon monoxide and Larginine-nitric oxide signalling pathways in vascular endothelial and netically hypertensive but not in normotensive rats [55] . Metalloporphyrin inhibitors of HO exert non-selective generated following induction of HO-1 in smooth muscle effects that may complicate the interpretation of expericells exposed to shear stress without iNOS induction. CO ments examining the vasodilator actions of CO. Zn and Sn liberated from smooth muscle cells exposed to shear, protoporphyrin are widely used as inhibitors of HO, but increased intracellular cGMP levels in co-incubated also inhibit sGC activity and can modulate NOS activity platelets and inhibited agonist-induced aggregation. The [59] . Although interpretation of the reported actions of CO heme oxygenase-CO pathway thus provides another line in the vasculature merit caution, there is now good of defence in atherogenesis and hypertension, by maintainevidence for a physiological role of heme oxygenase-CO ing blood flow and regulating platelet reactivity. In the pathway in vascular cells. In addition to activating sGC, context of atherosclerosis, impairment of the vascular NO vasodilator actions of CO appear to be mediated by direct signalling pathway could tip the balance in favour of HO 21 modulation of high conductance Ca -dependent potasas a salvage mechanism required to maintain vascular tone sium channels (K ) in vascular smooth muscle cells [60] . and function.
Ca CO induced increases in potassium efflux via K channels Ca would hyperpolarise smooth muscle cells and in turn 21 inactivate voltage-dependent Ca -channels and reduce 6. Regulation of heme oxygenase by hypoxia calcium sensitivity, leading to smooth muscle relaxation [61] . These changes in K channel activity have been Arterial wall hypoxia resulting from hypertension [70] Ca attributed to a chemical modification of specific amino acid and through the occlusion of the vasa vasorum [71] , has residues of the channel itself rather than to activation of been implicated in the pathogenesis of atherosclerosis. cGMP-dependent kinases [60] . Modulation of the memSeveral studies have reported that ischaemia / reperfusion brane potential by CO highlights another protective mechaupregulates HO-1 expression in porcine and rat hearts nism of the heme oxygenase pathway, since increased [72, 73] , and that hypoxia induces HO-1 levels in cultured 21 intracellular Ca levels in vascular smooth muscle cells vascular endothelial [74] and smooth muscle [35] [36] [37] cells. induced by oxLDL [62] would contribute to increased Hypoxia-dependent HO-1 gene activation in rat smooth vascular contractility observed in atherogenesis. muscle cells is mediated by a hypoxia-inducible factor-1 (HIF-1) [75] , initially identified as a nuclear factor that binds to the enhancer sequences of the erythropoietin gene 5. Interactions between the NO and CO signalling [76] . Hypoxia thus serves as an additional inducer of HO-1 pathways in the vasculature, mediated by mechanisms different from those activated by oxidative stress. However, the oxidative Accumulating evidence indicates that NO donors and stress responsive transcription factor NF-kB is also actiendogenously generated NO induce expression of HO-1 in vated in hypoxia [77] , and may contribute to the induction vascular endothelial and smooth muscle cells [34, 39, 42] .
of HO-1. Under hypoxic conditions, cAMP can regulate This provides an endogenous adaptive defence mechanism HIF-1 binding to the HRE [78] and thereby also modulate against the oxidative stress associated with sustained HO-1 induction. In this context, Durante et al. [79] production of NO [40, 63] . As the heme moiety of NOS recently reported that elevation of cAMP or analogues of and sGC can serve as alternate substrates for HO [11] , cAMP were able to induce HO-1 and generate CO in their activity may under certain conditions be downreguvascular smooth muscle cells. Induction of iNOS in lated. In addition, CO is able to bind to the heme moiety of vascular smooth muscle cells is also modulated by cAMP NOS, and thereby inhibit L-arginine turnover and NO [80] , suggesting that cAMP is an important regulator of production [11] . Due to the close similarity of NOS and both NO and CO signalling pathways under inflammatory NADPH-cytochrome P450 reductase, electron transfer conditions. from NOS to HO can also occur, fuelling heme catabolism
The significance for atherogenesis of HO-1 induction by by HO [11] . By reducing intracellular heme levels in hypoxia may lie in its ability to generate CO to modulate vascular cells, heme oxygenases may limit de novo vascular resistance, since eNOS expression is suppressed synthesis of iNOS, whilst the iron generated by heme by hypoxia [81] . Morita et al. [37] have reported that catabolism would further limit synthesis of iNOS through increased accumulation of cGMP in hypoxic smooth inhibition of nuclear transcription [64] . Expression of muscle cells was dependent on enhanced HO-1 expression iNOS has been detected in animal and human atherosand activity. Interestingly, hypoxia-induced release of CO clerotic lesions and contributes to the formation of peroxfrom smooth muscle cells inhibits gene expression of ynitrite [65] [66] [67] . Induction of HO-1 in atherogenesis in endothelin-1 and platelet-derived growth factor in co-culresponse to peroxynitrite [34] may attenuate vascular tured endothelial cells [35] . Moreover, increased proliferinjury by inhibiting iNOS activity.
ation of hypoxic smooth muscle cells in response to serum Shear stress induced vasodilatation is thought to be or mitogens is inhibited by CO, acting via a cGMPmediated by endothelium-derived NO [68] , however, dependent pathway involving transcriptional regulation of Wagner et al. [69] have recently reported that CO is also cell cycle progression genes [36] .
Heme oxygenase mediated antioxidant protection in atherogenesis
The role of HO-1 induction in cellular antioxidant defences in atherogenesis may be of greater importance than its involvement in vascular relaxation through CO generation. The clinical complications arising from atherosclerosis are directly related to elevated free radical b-actin mRNA levels were determined by Northern blot analysis [Siow & there is increasing evidence that low serum concentrations activity of protein kinase C (PKC) in human fibroblasts [89] . As many of the effects of atherogenic agents in vascular cells are mediated via activation of PKC [90] , C also attenuates the adaptive increases in glutathione bilirubin could also exert cytoprotection independent of its levels in human smooth muscle cells treated with oxidized known antioxidant properties. Although a cytoprotective LDL [29] , these findings provide further evidence that role for bilirubin generated from HO in vivo in man antioxidant supplementation may be anti-atherogenic. remains to be established, bilirubin acts as an antioxidant in rats in vivo treated with lipopolysaccharide [106] .
We have previously reported that mildly and highly 8. Future research -vascular gene transfer? oxidized LDL, but not native LDL, induce a time-(6-48 21 h) and concentration-(10-100 mg protein ml ) dependent
The potential for protecting vascular cells against oxidexpression of HO-1 in cultured vascular smooth muscle ant injury in atherogenesis is highlighted by recent reports cells [9] . In these studies, the degree of LDL oxidation was suggesting that HO-1 gene transfer confers vascular carefully defined according to their electrophoretic mobilities and lipid hydroperoxide content [91] . In similar studies in rat aortic smooth muscle cells, we confirmed that mildly oxidized and highly oxidized LDL, but not native LDL, increased mRNA levels for HO-1 (see Fig. 3A) . Ishikawa et al. [8] have recently reported that induction of HO-1 mRNA expression and activity in co-cultures of human aortic endothelial and smooth muscle cells by mildly oxidized LDL, oxidized lipid metabolites or hemin inhibits monocyte chemotaxis (see Fig. 3B ), an early event in atherogenesis [82] . This finding was attributed to the generation of bilirubin and biliverdin by endothelial cells, since monocyte chemotaxis was attenuated by pretreatment with these products heme metabolism and reversed by inhibition of HO activity. Our recent studies in human [38] . Together with our recent report that vitamin independent experiments (taken from [38] ). protection. The elegant studies by Abraham and co-workmice and was associated with no evidence of vascular cell ers [92, 93] have shown that transfection of the human injury or thrombosis. In contrast, rejected hearts from HO-1 gene into coronary endothelial cells attenuates the HO-1 deficient mice exhibited widespread apoptosis of damaging effects of free heme and modulates the cell vascular cells and myocytes, infiltration of host leukocytes, phenotype, inducing an angiogenic response to increase platelet aggregation and vascular thrombosis. blood vessel formation. Transfection of HO-1 into human pulmonary epithelial cells [94] and hamster fibroblasts [95] has also been reported to increase their resistance to Acknowledgements hyperoxic insult through the enhanced activity of HO-1. As levels of HO-1 are elevated in atherosclerotic lesions
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Recent studies by Ishikawa et al. [97] have shown that induction of HO-1 expression and activity in LDL receptor References knockout mice clearly inhibited the formation of atherosclerotic lesions, while Denery et al. [98] have reported that than NO [99] . As endothelium-derived NO synthesis and 
